Skip to main content
Equibles

Terry Evans

Fennec Pharmaceuticals Inc. (FENC)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Terry Evans

Fennec Pharmaceuticals Inc. reported in an 8-K filed October 30, 2024 that Terry Evans was appointed Chief Commercial Officer ("CCO"), effective October 28, 2024. Terry Evans has spoken on 2 earnings calls across 1 company, most recently for Fennec Pharmaceuticals Inc. on August 11, 2026.

“On October 28, 2024, Fennec Pharmaceuticals Inc.'s (the "Company") announced the appointments of Mr. Pierre S. Sayad, PhD, M.S., as Chief Medical Officer ("CMO"), Mr. Terry Evans as Chief Commercial Officer ("CCO"), and Ms. Christiana Cioffi, MBA, as Chief Strategy Officer ("CSO"), all of which became effective on October 28, 2024.”
Fennec Pharmaceuticals Inc. Form 8-K, filed October 30, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Fennec Pharmaceuticals Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.